Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC
Clinical trial NCT05292417 · UNKNOWN
Trial details
- NCT number
- NCT05292417
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2023-03-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.